F9 and Venous thrombosis: According to some expert opinion, activated PCC (aPCC) may be associated with a higher risk of thrombosis compared to non-activated PCC [625] due to the presence of activated factor IX, because the thrombogenic trigger associated with PCC infusion occurs at the level of factor X activation as a part of aPCC [626].